glp 1 antagonist medications List of approved and pending GLP-1 What is the pipeline for

Natarajan, A

Since then, liraglutide (Victoza and Saxenda, Novo Nordisk), dulaglutide (Trulicity, Eli Lilly), lixisenatide (Adlyxin, Sanofi-Aventis), semaglutide (Ozempic, Wegovy and Rybelsus, Novo Nordisk) and tirzepatide (Mounjaro and Zepbound, Eli Lilly) have been FDA approved for various indications

[DOI] [PMC free article] [PubMed] [Google Scholar] 13.Harrington A

"This is definitely a step in the right direction, but it's not necessarily getting the medicine to people who need it the most at a price that is affordable," Dr

The theoretical argument is simple: going sub q bypasses the gut and first-pass metabolism entirely, so in theory youd get close to 100% bioavailability versus the ~38% seen orally

2011 Sep 27;2:32